With healthcare at a key crossroads of policy, technology, and science, Sanofi CEO Paul Hudson shares the Big Pharma’s ...

Paul Hudson has a blunt view of peers who hand off the execution of their artificial intelligence strategy to their chief ...

Rabat — Multinational pharmaceutical and healthcare company Sanofi has announced the appointment of Rami Mroueh as chairman ...

A long-coveted deal to slash US steel and aluminium tariffs to zero has been shelved on the eve of Donald Trump’s state visit ...

Data from the late-stage trial of amlitelimab weren’t as strong as the results seen in Phase 2, adding to doubts about a drug ...

GSK announced plans to invest $30bn across the US in research and development and supply chain infrastructure over the next five years. This includes a new $1.2bn investment in advanced manufacturing ...

Les grandes entreprises ont été très généreuses avec leurs dirigeants cette année. Aux Etats-Unis, au Royaume-Uni, en Suisse, ...

Sanofi shares plunged after its experimental drug for the skin condition atopic dermatitis disappointed investors with a less-than-expected benefit in a late-stage trial.After 24 weeks of treatment, ...

Effective change management is the linchpin of enterprise-wide AI implementation, yet it’s often underestimated. I learned ...

Sentiment soured in May when Sanofi reported the failure of a phase 3 trial of its Regeneron-partnered IL-33 drug candidate ...

Sanofi ( NASDAQ: SNY) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 1:05 PM EDT ...

This year’s Fierce Pharma Marketing Awards ceremony, which took place in Philadelphia on Wednesday night, saw several major ...